Cargando…
Intraventricular Topotecan for the Treatment of Neoplastic Meningitis: Five Case Studies
Many systemic cytotoxic agents cannot penetrate the blood-brain barrier. Because of this, in approximately 5% of cancer cases, metastatic disease is seen in the leptomeninges. Without treatment, patients with neoplastic meningitis (NM) generally survive for only a matter of weeks. In the treatment o...
Autores principales: | Walker, Julie, Schultz, Diana, Grisdale, Kathleen, Groves, Morris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Harborside Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4093345/ https://www.ncbi.nlm.nih.gov/pubmed/25031951 |
Ejemplares similares
-
Development and Validation of an HPLC Method for Analysis of Topotecan in Human Cerebrospinal Fluid and Its Application in Elimination Evaluation of Topotecan after Intraventricular Injection
por: Yoshikawa, Naoki, et al.
Publicado: (2021) -
Continuous and bolus intraventricular topotecan prolong survival in a mouse model of leptomeningeal medulloblastoma
por: Shackleford, Gregory M., et al.
Publicado: (2019) -
Novel Therapeutic Approaches in Neoplastic Meningitis
por: Khosla, Atulya Aman, et al.
Publicado: (2022) -
Neoplastic meningitis in solid tumors: from diagnosis to personalized treatments
por: Pellerino, Alessia, et al.
Publicado: (2018) -
How to Recognize and Treat Neoplastic Meningitis
por: Fields, Margaret M.
Publicado: (2013)